Zenas BioPharma sets price range for $200 million initial public offering

By / / Finance / 1 minute of reading




Zenas BioPharma Inc., a Waltham, Mass.-based developer of immunology-based therapies, on Friday said it plans to offer 11.76 million shares of common stock at an estimated price range of $16 to $18 in its upcoming initial public offering.



Source link

About The Author

Avatar of Amanda Pierce
Amanda Pierce is a writer who has covered sports, education, and tech for Highland Loch Press. She also writes about her hobbies—which include hiking, traveling to new places, and cooking.

Start typing and press enter to search

Scroll to Top